Faze Three grants 3.31 lakh ESOPs under 2024 scheme
Faze Three Limited granted 3,31,154 ESOPs under its 2024 scheme, split into two tranches priced at ₹10 and ₹425. Vesting occurs over 1-5 years, with a 5-year exercise window post-vesting.

*this image is generated using AI for illustrative purposes only.
Faze Three Limited has granted 3,31,154 employee stock options to eligible employees under the Faze Three Employee Stock Option Scheme 2024. The options are exercisable into an equal number of fully paid-up equity shares with a face value of ₹10 each. This approval was granted by the company's Nomination and Remuneration Committee on June 29, 2026, in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The grant is divided into two tranches with distinct pricing and vesting structures. A total of 1,24,000 options have been priced at ₹10 per share, while the remaining 2,07,154 options carry a price of ₹425 per share. The options are issued to align employee interests with company growth and incentivize long-term performance.
Grant and Vesting Details
The vesting schedules differ based on the tranche. The lower-priced options will vest after one year from the date of grant. The higher-priced options will vest over a period of five years from the grant date in equal annual instalments of 20%.
| Options Granted | Price per Share | Vesting Period |
|---|---|---|
| 1,24,000 | ₹10 | 1 year from date of grant |
| 2,07,154 | ₹425 | 5 years in equal 20% instalments |
Exercise Terms
The exercise period for the granted options is five years from the date of respective vesting. The scheme is fully compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The disclosure was submitted to BSE Limited and National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Historical Stock Returns for Faze Three
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.83% | +3.73% | +19.26% | +36.57% | +2.82% | +97.15% |
How will the significant price disparity between the two tranches impact employee retention and motivation over the long term?
What specific performance metrics or milestones are tied to the vesting of the higher-priced options?
Could this ESOP grant signal an upcoming expansion phase or strategic shift for Faze Three Limited?































